Beryl Drugs Ltd

Pursuant to regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 In this connection we are pleased to enclose the following:-A. Statement of Audited Financial Results for the quarter and year ended 31st March 2023 Statement of Assets and Liabilities and Cash Flow Statement.B. Independent Auditors Report on Audited Annual Financial Results for the quarter and year ended 31st March 2023 by the Statutory Auditor M/s Subhash Chand Jain Anurag & Associates Chartered Accountants.C. Declaration in respect of statement of impact of audit qualifications.